1 |
N'dilimabaka N, Mounguegui DM, Lekana-Douki SE, Yattara MK, Obame-Nkoghe J, Longo-Pendy NM, Koumba IPK, Mve-Ella OLB, Moukouama SK, Dzembo CE, Bolo LY, Biyie-Bi-Ngoghe P, Mangouka GL, Nzenze JR, Lekana-Douki JB. Biochemical and hematological factors associated with COVID-19 severity among Gabonese patients: A retrospective cohort study. Front Cell Infect Microbiol 2022;12:975712. [PMID: 36619758 DOI: 10.3389/fcimb.2022.975712] [Reference Citation Analysis]
|
2 |
Yu Y, Li X, Wan T. Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis. Dig Dis Sci 2022;:1-17. [PMID: 36085229 DOI: 10.1007/s10620-022-07687-2] [Reference Citation Analysis]
|
3 |
Ulgen A, Cetin S, Cetin M, Sivgin H, Li W. A composite ranking of risk factors for COVID-19 time-to-event data from a Turkish cohort. Comput Biol Chem 2022;98:107681. [PMID: 35487152 DOI: 10.1016/j.compbiolchem.2022.107681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Caruso S, Aloisio E, Dolci A, Panteghini M. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value. Clin Chem Lab Med 2022;60:135-42. [PMID: 34687597 DOI: 10.1515/cclm-2021-0824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Sosnowska B, Bielecka-dabrowa A, Banach M. Prognosis in COVID-19 Patients: Statistics, Risk Factors. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_5] [Reference Citation Analysis]
|
6 |
Aloisio E, Panteghini M. Aspartate aminotransferase in COVID-19: A probably overrated marker. Liver Int 2021;41:2809-10. [PMID: 34609789 DOI: 10.1111/liv.15068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|